Нарушение растворения капсулы и сшивка желатина: Причины, Тестирование, Решения для хранения и упаковки

A capsule passes dissolution testing after production, but several months later the same product fails during a stability study. What changed? А capsule dissolution failure does not automatically mean the API or formulation is the problem. In gelatin capsules, the shell itself can change over time. Reactive compounds such as aldehydes, together with heat, влажность, formulation–shell interactions, и условия хранения, can promote gelatin cross-linking. The shell may then form a thin, poorly soluble membrane known as a pellicle, slowing or preventing the capsule from opening and releasing its contents. But cross-linking is only one possible cause—poor API solubility, excipient interactions, производительность упаковки, and even the dissolution method also need to be investigated. В этом руководстве, we will work through these factors step by step and show how to identify the root cause, choose the right testing approach, and reduce the risk through better formulation, хранилище, обработка, и упаковка.

What Is Capsule Dissolution Failure?

А capsule dissolution failure occurs when a capsule product does not meet its specified dissolution acceptance criteria under the applicable test conditions. In a normal dissolution test, the capsule should become wetted, open or disintegrate, release its fill, and allow the active drug to dissolve into the test medium.

In simplified terms: Wetting → shell swelling → shell rupture → fill release → API dissolution

Однако, these steps can be disrupted by problems with the capsule shell, формулировка, Условия хранения, упаковка, or dissolution method. Например, a gelatin capsule exposed to certain reactive compounds, температура, or humidity may develop gelatin cross-linking and a poorly soluble membrane known as a pellicle. The shell may then swell or become rubbery instead of opening normally, задержка выпуска препарата.

It is important to distinguish disintegration vs dissolution. Disintegration refers to the capsule breaking apart or dissolving its shell; dissolution refers to the active drug solubilizing in the medium. A capsule can disintegrate (crack open) yet still fail to meet dissolution criteria if the API itself doesn’t dissolve quickly. Наоборот, a capsule that never disintegrates obviously can’t release its drug. When we talk about “capsule dissolution failure,” it generally means the filled capsule as a whole failed the dissolution test – often because the shell did not open (or the drug didn’t come out) within the required time.

Common signs of capsule dissolution failure include:

• The capsule remains intact or only partially opens.
• Тонкий, rubbery or gelatinous pellicle remains after testing.
• The fill remains trapped inside the capsule.
• Dissolution becomes slower after storage or stability testing.
• Capsules open normally, but the API dissolves too slowly.

These observations can help determine whether the problem is more likely related to the оболочка капсулы, формулировка, хранилище, упаковка, or dissolution test method. USP <711> provides the general dissolution testing framework, пока USP <1094> addresses dissolution testing and related quality attributes for capsules.

Gelatin Cross-Linking and Pellicle Formation

A major cause of delayed dissolution is gelatin capsule cross-linking. Chemically, cross-linking is when reactive groups form covalent bonds between gelatin polymer chains, making the shell much less soluble. In the presence of tiny amounts of aldehydes or similar reactive compounds, or under high temperature/humidity, gelatin molecules can form bridges that are essentially irreversible. Это создает тонкий, стеклянный pellicle on the inside (and/or outside) of the capsule shell, instead of the shell simply dissolving. The pellicle blocks water penetration and holds the fill inside, so the drug cannot be released into the medium. The result is a typical chain of events: Gelatin cross-linking → pellicle formation → delayed shell rupture → delayed fill release → capsule dissolution failure.

A simple flowchart illustrates the difference:

На практике, cross-linked capsules often leave a thin gelatinous membrane (pellicle) after the test. Researchers note that in dissolution testing, cross-linked gelatin is “characterized by a bridge across the peptide backbone… which creates water insoluble membranes or pellicles”. Another study describes that cross-linking leads to “the formation of a pellicle on the internal or external surface of the gelatin capsule shell that prevents the capsule fill from being released”. The key point: cross-linking makes the capsule shell harder, water-resistant, and slow to open. Any fill trapped inside will release only very slowly, if at all.

What Causes Capsule Dissolution Failure?

Capsule dissolution problems can stem from multiple factors. In the case of gelatin cross-linking, primary causes are reactive chemicals and environment. But formulation and testing issues also play a role. Key causes include:

• Aldehydes and reactive impurities. Traces of formaldehyde, glutaraldehyde, oxidized fats, or even reducing sugars can attack gelatin. Например, antioxidants or вспомогательные вещества that degrade may generate aldehydes that catalyze cross-linking. This is well-documented: one review notes “gelatin in the presence of certain compounds, mainly aldehydes… can cross-link”.
• High temperature and humidity. Heat and moisture accelerate cross-linking. Exposing gelatin shells to 40 °C/75% относительной влажности (common accelerated stability conditions) can trigger cross-linking over weeks or months. Действительно, one case study found a capsule formulation dissolved normally at launch but slowed significantly after three months at 40 °C/75% относительной влажности. Humidity itself doesn’t “cause” cross-links chemically, but it plasticizes gelatin and enables the reactive chemistry. The combination of warm, moist storage is often what turns a fine capsule batch into a failed one.
• API–shell and excipient–shell interactions. The fill formulation can contribute to problems. Some APIs or excipients can adsorb or react with the shell. Например, highly acidic or basic fills, or hygroscopic substances, may alter the local pH or water content at the shell interface. Oxidizing APIs or lipid-based fills can generate reactive peroxides or aldehydes over time that eventually cross-link gelatin. Even flavors, цвета, or coatings within the fill can migrate into the shell. If the capsule’s drug or excipient is incompatible with gelatin, the dissolution may slow. Наоборот, an impervious capsule shell (due to cross-linking) might mislead one to think the formulation is the issue, so careful analysis is needed.
• Capsule shell material. Most dissolution failures linked to cross-linking involve твердые желатиновые капсулы. Plant-based alternatives (HPMC/cellulose capsules) делать not cross-link via this aldehyde chemistry. Cellulose capsules may still have stability issues, but they won’t produce a protein-based pellicle. (Примечание: if a HPMC capsule appears gelatinous, it’s likely due to excessive moisture rather than true cross-linking.) For standard gelatin shells, the type of gelatin (bovine vs porcine, bloom strength, plasticizer content) can influence sensitivity. В любом случае, HPMC capsules require a different analysis strategy; for gelatin shells, cross-linking is a unique risk.
• Packaging and headspace environment. The choice of container influences capsule humidity over time. A poorly sealed bottle can allow moisture uptake or loss, altering shell properties. Materials or liners that emit or scavenge volatiles also matter. Например, certain silica gel packs or activated carbon in the package can absorb aldehydes and moisture, protecting capsules. С другой стороны, packaging materials themselves (like adhesives or coatings) might leach reactive substances. В общем, if capsules are packed without a desiccant in a permeable pouch or bottle, the variable headspace humidity can make cross-linking much more likely during storage.
• Dissolution test method issues. Sometimes the problem is not the capsule but the test. Например, dissolution media or surfactants (like SLS) can denature the enzyme used in Tier II tests, masking true behavior. Также, an unsuitable apparatus (например. too low paddle speed) might yield seemingly slow dissolution. It’s vital to confirm that a failed test is not due to equipment or method error. The USP <711> chapter notes that enzyme-containing media (Tier II) are allowed only after confirming cross-linking, not as a routine fix.

Стол 1 summarizes how different observations may suggest different causes:

Стол 1. Observations vs. Possible Causes in Dissolution Failure

Shell Problem or Formulation Problem? A Practical Diagnostic Approach

When dissolution fails, it’s crucial to tell whether the оболочка капсулы или заполнить формулировку виноват. The table below compares key indicators.

Стол 2: How to distinguish capsule shell cross-linking vs formulation issues in dissolution failure. Use a capsule-switch test for a definitive clue. If moving the contents to a fresh shell normalizes dissolution, the problem was the old shell.

Diagnosing Capsule Dissolution Problems

When dissolution fails, we follow a diagnostic workflow. A decision tree helps isolate the root cause. Первый, re-run the test under controlled conditions. Inspect the capsules: if many remain intact with a pellicle, shell cross-linking is likely. If the shells opened normally but the powder is undissolved, the issue is probably the formulation or API.

Troubleshooting steps:

1. Check Shell Rupture: Did capsules truly fail to open? Если да, cross-linking is strongly suspected. If capsules do open, move on.
2. Look for a Pellicle: Any thin film or rubbery mass on the shell? This is hallmark evidence of cross-linked gelatin.
3. Compare Fresh vs Aged Samples: If the fresh (T=0) batch passes and only the stability-aged ones fail, this points to an ageing or storage effect (например. перекрестные ссылки с течением времени).
4. Switch Capsule Shell: Если возможно, empty the fill from an aged capsule and place it in a new, non-aged gelatin shell (or even an HPMC shell) and test again. If it dissolves normally, the original shell was at fault.
5. Check Formulation Solubility: Independently dissolve the API and excipients. Consider adding enzymes or different media: if enzyme dramatically improves release, cross-linking might be at play (since enzymes digest the pellicle). If even pure drug has slow dissolution, focus on formulation.
6. Review Stability Data: Examine storage conditions (temperature/RH) and any excursions. If high heat/humidity were present, cross-linking risk is high.
7. Evaluate Packaging and Storage: Check packaging integrity, содержание влаги (loss on drying) капсул. Look for desiccant use or headspace humidity.

A concise decision tree helps:

Стол 3 below provides further cues on what to check in each area:

Стол 3. Investigation Checklist for Capsule Dissolution Failure

These structured checks and the decision tree guide the investigation. На практике, confirming cross-linking vs formulation является ключевым. Например, if capsules open normally but release is still slow, adding digestive enzymes to the medium often does нет help, indicating the problem lies in the formulation or drug solubility, not gelatin cross-linking. USP and scientists emphasize this point: adding enzymes is only justified when evidence points to cross-linked gelatin, not as a default fix.

USP Dissolution Testing (Tier I and Tier II)

The USP <711> “Dissolution” chapter (and related USP 1094 capsule guidance) lays out how to test hard capsules. The standard test (Tier I) uses compendial media (например. 0.1 N HCl or buffers, often with gentle agitation). If a batch fails Tier I, one must first confirm that the equipment and method are correct. If a cross-linked shell is suspected (см. выше), USP allows a Tier II test using digestive enzymes to break down the gelatin pellicle.

• Tier I (Standard Dissolution): Perform the usual compendial dissolution test. If the capsules do not meet the acceptance criterion, осмотреть капсулы. Are they partially gelatinous? Is there evidence of a pellicle? Если да, the test is likely reflecting shell cross-linking. If the shells opened fine, consider method issues.
• Tier II (Enzyme-Assisted): If cross-linking is confirmed, the USP recommends re-testing with enzymes: обычно pepsin for acidic medium (pH ≤6.8) и pancreatin (a mix including trypsin, amylase, protease) for neutral to basic medium. Например, Marques et al. describe adding 750,000 units/L of pepsin in 0.01 N HCl (рН 1.2) для 5 минуты, then adding surfactant. The idea is that the enzyme digestion breaks down the cross-linked gelatin, allowing the fill to dissolve. Важно, USP <711> says enzymes should only be used when justified by gelatin cross-link evidence. The revised USP guidelines (Stimuli article by Gray et al. 2014) explicitly recommend pepsin or pancreatin and even papain/bromelain for intermediate pH, along with pre-treatment steps to accommodate surfactants.

Суммируя, Tier II dissolution is a two-stage test: first incubate capsules in enzyme medium (no surfactant) for a short time, then complete dissolution (often adding surfactant afterward). If Tier II passes, it confirms that the cross-linked gelatin was impeding release. Однако, passing Tier II does not automatically excuse a formulation; it simply documents that the standard test failure was due to shell chemistry, not drug potency.

Storage and Stability Effects

Storage conditions greatly impact capsule dissolution behavior. Температура и относительная влажность have the strongest effects on gelatin shells. Теплый, humid warehouses or tropical climates can quickly induce cross-linking. Even short excursions (например. during shipping) can start irreversible reactions in susceptible shells. The ICH accelerated stability condition (40 °C/75% относительной влажности) is a useful stress test. If a batch fails after just 3–6 months at these conditions, cross-linking is highly likely.

An illustrative case: One manufacturer found that a capsule blend passed dissolution at release but dramatically slowed after 3 months at 40 °C/75% относительной влажности. The rate change correlated with visible pellicle on the capsules. This mirrors FDA experience: in one drug application review, dissolution failures at accelerated stability prompted enzyme testing, confirming gelatin cross-linking (despite acceptable initial results).

Время is also a factor. Cross-linking can continue to develop over a product’s shelf life. A few months on shelf in a warm warehouse can change dissolution. Regular testing at intermediate stability points (3, 6 месяцы) имеет решающее значение. If even the “real-time” condition (например. 25°C/60%RH) is above normal room humidities, some formulations may gradually cross-link.

В итоге, whenever a capsule batch unexpectedly fails dissolution after storage, просить: Were they exposed to heat or humidity? If the failure is stability-dependent (fresh ok, aged not), focus on packaging and environment.

How Packaging Can Prevent Capsule Dissolution Failure

Packaging is the customer’s first line of defense against cross-linking. The right container-closure system can limit moisture and reactive gas ingress, significantly preserving dissolution performance. Key strategies include:

• Упаковка бутылки (HDPE or Glass): Bottles should have tight closures and often include a silica desiccant пакет. Индукционная герметизация (foil seal under the cap) helps prevent moisture changes. Some companies even use activated carbon canisters inside HDPE bottles: Likar et al. showed that putting capsules in bottles with activated carbon drastically improved stability under 40 °C/75% относительной влажности. The carbon likely scavenges trace aldehydes and moisture. For highly sensitive products, using multi-layer bottles (with low O₂ and H₂O transmission) plus monitoring headspace humidity can pay off. Ensure the bottle is opaque if light-sensitive, since UV can accelerate gelatin degradation.
• Блистерная упаковка: Волдыри can offer higher moisture barriers than bottles, but it depends on material. Common PVC blisters have poor moisture resistance. PVC with PVDC coat (ПВХ/ПВДХ) is better, and PCTFE/Aclar or Aluminum-Aluminum (Все время) foils offer the highest barrier. Например, for a very hygroscopic capsule, а Алю-Алу блистер is often used. Note that an Alu-Alu blister (all foil) prevents moisture and light, but is more expensive and harder to open. Use blisters especially if разовая упаковка is preferred or if humidity is a big risk.
• Desiccants and Oxygen Scavengers: Adding a desiccant packet to a bottle is standard for moisture. Silica gel or molecular sieve will keep RH low. For oxygen-sensitive APIs (even if gelatin is main concern, oxidation can produce aldehydes), consider oxygen absorbers. The Likar study suggests activated carbon can serve dual roles.
• Packaging Recommendations: Стол 3 outlines common risks and packaging directions.

Стол 4. Packaging Considerations for Capsule Stability

(Примечание: For more on capsule primary packaging options, увидеть Джинлу Capsule Packaging Guide.)

На практике, the packaging decision often comes down to balancing cost vs. защита. А линия наполнения капсул (как Джинлу Packing machines) can be outfitted to добавить осушители, induction seals, and to leak-test бутылки или блистеры. Proper packaging line controls (like vacuum chambers for induction sealing, controlled humidity filling) help ensure the intended barrier is achieved on every unit.

Preventing Capsule Cross-Linking: 7-Step Checklist

Mitigation is best done early in development and during production. Вот 7 preventive steps:

1. Screen Ingredients: At formulation stage, review APIs and excipients for reactive impurities. Avoid ingredients known to contain aldehydes (например. some preservatives) or reduce agents. Test for glycation products or oxidized PEGs. If unavoidable, source pharmaceutical-grade materials with minimal impurities.
2. Evaluate Shell-Fill Compatibility: Conduct a capsule compatibility study. Например, store empty shells vs filled capsules under stress and compare. If problems appear only in filled capsules, examine interactions (НАПРИМЕР., liquid fills may plasticize shells).
3. Control Manufacturing Environment: During capsule filling and drying, maintain low RH (ideally <40%) in the production area. Use dehumidifiers in the капсульный наполнитель и покрытие rooms. Minimize hold times of capsules exposed to air. (Для мягкие капсулы, control fill temperature and drying too.)
4. Monitor Shell Quality: Check the gelatin shell properties (содержание влаги, bloom strength) from each batch. Do not use shells with unusually high moisture for hard capsules, as they’re prone to cross-link. Сходным образом, avoid extremely low moisture which can embrittle shells or attract water later.
5. Тестирование стабильности: Perform accelerated and long-term stability tests on the filled capsules, using the final packaging. Include a dissolution test at each stability point. Early detection of any slowdown lets you act (НАПРИМЕР., reformulate or change packaging).
6. Packaging Selection: Choose a high-barrier primary package based on stability data. Например, if capsules showed 5% dissolution loss after 3 months at 40 °C/75%RH in bottles without desiccant, switch to a blister or add desiccant for better protection.
7. Process Controls: Implement line controls that track humidity and temperature. Use automated SCADA or alarms on RH. Employ in-line moisture analyzers for capsule shells if available. Always follow a written procedure for handling gelatin capsules (which are hygroscopic), and train operators on quick packaging to minimize exposure.

These steps form a quality-by-design approach. By anticipating cross-linking as a risk, we can build in controls to keep capsules robust through their shelf-life.

Заключение

Capsule dissolution failure is often a multi-factor issue. Don’t assume early failures are formulation problems only – check the shell. Gelatin capsule cross-linking is an infamous culprit: small amounts of aldehydes or a hot, humid environment can trigger it, forming a pellicle that traps the drug. Identifying cross-linking requires careful observation (looking for membranes on the shell), comparison of fresh vs aged samples, and possibly a dissolution retest with enzymes. Once diagnosed, the solution is multifaceted: optimize formulation to eliminate reactive impurities, control manufacturing humidity, и choose a strong packaging system (например. bottles with desiccant or foil blisters).

For capsule drug manufacturers, it’s critical to integrate dissolution checks throughout development and to think holistically: shell chemistry + формулировка + обработка + packaging = final performance. If you’re planning or upgrading a capsule production line, Contact JinLu Packaging for comprehensive solutions. Наш Капсульные машины для заполнения, induction sealing equipment, и линии блистерной упаковки are designed with precision controls (влажность, уплотнение, in-line inspection) to help you avoid issues like cross-linking and dissolution failure.

FAQs on Capsule Dissolution Failure and Gelatin Cross-Linking

Ссылки：
1.Capsules—Dissolution Testing and Related Quality Attributes —— USP <1094>
2.Enzymes in the Dissolution Testing of Gelatin Capsules —— Национальная библиотека медицины
3.Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity —— ПабМед
4.Испытание стабильности новых лекарственных веществ и продуктов —— Я Q1A(Р2)
5.The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules —— ПабМед
6.Influence of enzymes and surfactants on the disintegration behavior of cross-linked hard gelatin capsules during dissolution —— ПабМед